Jiangsu Bioperfectus Technologies Co., Ltd.
SSE:688399.SS
74.43 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -2.002 | -373.811 | 1,827.9 | 1,193.214 | 819.567 | 83.756 | 63.825 | 42.668 | 8.361 |
| Depreciation & Amortization
| 58.697 | 78.914 | 93.971 | 41.33 | 22.084 | 17.363 | 13.872 | 9.7 | 5.921 |
| Deferred Income Tax
| 0 | -4.994 | -59.654 | -1.144 | -8.42 | -3.444 | -2.158 | 0.109 | 0.688 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.331 |
| Change In Working Capital
| 69.755 | -67.786 | -327.762 | -249.173 | 105.769 | 2.225 | 12.968 | 12.338 | -15.099 |
| Accounts Receivables
| 16.853 | 636.903 | -660.362 | -253.88 | -166.418 | -20.695 | -10.07 | -1.76 | -4.643 |
| Inventory
| 11.131 | 33.96 | -186.29 | -91.103 | -144.747 | -4.974 | 4.236 | -2.72 | -5.46 |
| Accounts Payables
| 0 | -733.655 | 578.544 | 96.954 | 425.354 | 31.338 | 0 | 0 | 0 |
| Other Working Capital
| 41.771 | -4.994 | -59.654 | -1.144 | -8.42 | -3.444 | 8.732 | 15.058 | -9.639 |
| Other Non Cash Items
| 19.474 | 254.534 | 370.769 | 0.151 | -11.539 | 3.375 | -4.846 | -3.115 | 22.91 |
| Operating Cash Flow
| 145.925 | -113.144 | 1,964.878 | 985.523 | 935.881 | 106.719 | 85.819 | 61.591 | 22.093 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -62.861 | -111.34 | -350.741 | -303.615 | -134.558 | -105.775 | -98.739 | -29.306 | -22.373 |
| Acquisitions Net
| 0 | 4.104 | 13.943 | 6.085 | 9.542 | 1.35 | 0 | 0.536 | 0.116 |
| Purchases Of Investments
| -3,301.593 | -2,287.717 | -2,856 | -1,744 | -692 | -580 | -206 | -536.5 | -565 |
| Sales Maturities Of Investments
| 2,357.197 | 2,457.3 | 2,385.831 | 1,423.61 | 898.452 | 195 | 408.571 | 542.008 | 401.548 |
| Other Investing Activites
| 134.244 | 400 | 89.079 | -130.714 | -341.034 | -165 | -179.24 | 5.279 | -5 |
| Investing Cash Flow
| -873.013 | 462.348 | -717.888 | -748.635 | -259.598 | -654.424 | -75.408 | -17.983 | -190.708 |
| Financing Activities: | |||||||||
| Debt Repayment
| 70.697 | 71.98 | -65.022 | 99.85 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -7.077 | -6.035 | -586.2 | -322.41 | -175.86 | 0 | 0 | -34.289 | -3.891 |
| Other Financing Activities
| -158.375 | -10.686 | -11.817 | -8.409 | 49.966 | 612.934 | 0 | 0 | 102.285 |
| Financing Cash Flow
| -94.756 | 55.259 | -667.426 | -234.003 | -125.894 | 612.934 | 0 | -34.289 | 98.394 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0.85 | -1.266 | 0.757 | -1.535 | -1.632 | 0.007 | 0.004 | 0 | 0 |
| Net Change In Cash
| -820.994 | 403.197 | 580.322 | 1.35 | 548.757 | 65.236 | 10.415 | 9.32 | -70.221 |
| Cash At End Of Period
| 810.008 | 1,631.002 | 1,227.805 | 647.483 | 646.133 | 97.375 | 32.14 | 21.724 | 12.405 |